Tazact (Piperacillin/Tazobactam) Dosing for Patients with Creatinine Clearance of 24 mL/hr
For patients with creatinine clearance of 24 mL/hr, the recommended dose of Tazact (piperacillin/tazobactam) is 2.25 g every 6 hours for nosocomial pneumonia or 2.25 g every 8 hours for all other indications. 1
Dosage Recommendations Based on Renal Function
For patients with creatinine clearance between 20-40 mL/min:
For patients with creatinine clearance less than 20 mL/min:
Administration Considerations
- Administer piperacillin/tazobactam by intravenous infusion over 30 minutes 1
- For patients on hemodialysis, an additional dose of 0.75 g should be administered following each dialysis session on hemodialysis days 1
- Post-dialysis administration is preferred to facilitate drug delivery and avoid premature clearance of the drug 2, 3
Pharmacokinetic Considerations in Renal Impairment
- Both piperacillin and tazobactam are cleared by the kidneys, and their clearance correlates with renal function 4
- The half-lives of piperacillin and tazobactam are significantly prolonged in patients with renal impairment 4
- Dosage alterations are recommended for creatinine clearance values less than 40 mL/min to prevent drug accumulation 4
Monitoring Recommendations
- Therapeutic drug monitoring (TDM) is suggested for patients with impaired renal function 2
- Measure plasma trough concentration in case of intermittent administration and plasma steady-state concentration in case of continuous administration 2
- Perform TDM 24 to 48 hours after treatment initiation, after any dosage change, or with significant changes in clinical condition 2
Risk of Acute Kidney Injury
- Higher doses of piperacillin/tazobactam (4.5 g) may increase the risk of acute kidney injury in patients with pre-existing renal impairment 5
- Monitor renal function regularly during treatment, especially with higher doses 5
Alternative Dosing Strategies
- Continuous infusion may be considered for severe infections to optimize antibiotic exposure and pharmacokinetic/pharmacodynamic target attainment 6
- For continuous infusion in patients with impaired renal function, dose adjustment is still necessary based on creatinine clearance 7
Common Pitfalls to Avoid
- Avoid using standard dosing regimens without appropriate adjustments for renal impairment 3
- Do not administer before dialysis sessions as this would lead to premature removal of the drug 3
- Avoid excessive accumulation by properly spacing doses according to the degree of renal impairment 3
- Be cautious with higher doses (4.5 g) in patients with pre-existing renal impairment due to increased risk of acute kidney injury 5
Remember that the goal of dosage adjustment in renal impairment is to maintain therapeutic drug levels while avoiding toxicity due to drug accumulation.